APOB and atherosclerosis: Inflammation is known to accelerate atherosclerosis development in patients with JSLE [42], therefore the immune cell profile of JSLE patients in the High vs Low ApoB:ApoA1 groups was evaluated by logistic regression analysis (adjusted for BMI, sex, age, ethnicity, disease duration, treatment, SLEDAI-2000, hsCRP, dsDNA, and C3) in matched patient samples to the baseline metabolomics.